FREE SHIPPING IN ITALY

DOLATROX^®hcc is a medical device with EU trademark in conformity with MDD 93/42/EEC directives and following amendments and supplements, containing hyaluronic acid obtained by fermentation and not chemically modified, chondroitin sulfate of marine origin and cyclodextrin. DOLATROX^® hcc is a transparent solution, sterile, non-pyrogenic and viscoelastic supplied in a 3 ml syringe.

USED SUBSTANCES…

• HYALURONIC ACID SODIUM SALT (20 mg/ml):hyaluronic acid is a natural polysaccharide present in many human tissues, particularly in the synovial fluid; it acts in the joints both as cartilage and ligaments lubricant and as a shock absorber. According to many studies, the injections of hyaluronic acid in the joints affected by osteoarthritis restore the viscosity and elasticity of the synovial fluid, with a consequent pain mitigation and joint mobility improvement.
• CHONDROITIN SULFATE (of marine origin) (20 mg/ml): the chondroitin sulfate is a high molecular weight glycosaminoglycan which is part of the essential constituent components of the articular cartilage. In vitro, the chondroitin sulfate has shown ability to inhibit the hyaluronidase, i.e. the enzymes that degrade hyaluronic acid by hydrolyzing the ties.
• HYDROXYPROPYL- BETA-CYCLODEXTRIN (10mg/ml): Cyclodextrins are cyclic oligosaccharides able to improve the water solubility of certain substances, strengthening their stability and changing their aggregation state from liquid to viscous. Thanks to the cyclodextrins viscosity skill, this solution of hyaluronic acid and chondroitin sulfate highlights physical characteristics such as to ensure a better effectiveness.

Read More